Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections
CorA shows strong in vitro activity against a broad range of staphylococcal strains, particularly methicillin-resistant isolates. Its additive effects with clinically relevant antibiotics further support its potential in combination therapy for the treatment of resistant staphylococcal infections.
Authors
- Tanja Schneider (ORCID: https://orcid.org/0000-0001-7269-4716)
- Frank Sebastian Fröschen (ORCID: https://orcid.org/0000-0002-6458-264X)
- Marijo Parčina (ORCID: https://orcid.org/0009-0005-2275-633X)
- Achim Hoerauf (ORCID: https://orcid.org/0000-0002-8671-3831)
- Gabriele Bierbaum (ORCID: https://orcid.org/0000-0002-2933-8473)
- Sabina Karačić (ORCID: https://orcid.org/0000-0003-0440-2456)
- Miriam Grosse
- Gunnar Hischebeth
- Jesenko Karačić
- Andrea Schiefer
- Kenneth Pfarr
Institutions
- University Hospital Bonn (DE)
- German Center for Infection Research (DE)
- Helmholtz Centre for Infection Research (DE)
Publication Details
- Journal
- Infection
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1007/s15010-026-02760-8
- Primary Topic
- Microbial Metabolism and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsches Zentrum für Infektionsforschung